Yurtdışı Kongre Tebliğleri
(Kronolojik sıra)
1.Çorakçı A.,
Beyhan Z., Bolu E., Özata M., Azal Ö., Gündogan MA.
: The Effect of insulin therapy on apolipoproteins
in non-insulin dependent diabetes mellitus. Diabetes,
vol.40 (Supplement); Abstract No: 1571, 1991. 14th
International Diabetes Federation Congress. June
23-28, 1991. Washington DC, USA
2. Azal Ö., Özata
M., Bolu E., Beyhan Z., Çorakcı A., Gündogan MA. :
Comparison of serum sialic acid levels with HbA1C
and fructosamine levels in patients with diabetes
mellitus. VII. Balkan Congress of Endocrinology. May
27-29, 1992, Pleven, Bulgaria.
3.Özata M.,Azal Ö.,
Bolu E., Barut A., Çorakcı A., Beyhan Z., Gündoğan
MA. : HLA class I antigens in Turkish patients with
Graves’ disease. VII. Balkan Congress of
Endocrinology. May 27-29, 1992, Pleven, Bulgaria.
4.Özata M.,, Azal
Ö., Bolu E., Çorakcı A., Beyhan Z., Gündoğan MA. :
Treatment of hirsutism with cyproterone acetate and
ethinyl oestradiol. VII. Balkan Congress of
Endocrinology. May 27-29, 1992, Pleven, Bulgaria.
5.Bolu E., Azal Ö.,
Özata M.,Beyhan Z., Aslan N., Çorakcı A., Gündoğan
MA.: Alterations of lipid metabolism in men with
hypogonadism. VII. Balkan Congress of Endocrinology.
May 27-29, 1992, Pleven, Bulgaria.
6.Çorakcı A., Bolu
E., Özata M.,Azal Ö., Beyhan Z., Özdemir Ç.,
Gündogan MA.: Elevated plasma endothelin in non-insulin
dependent diabetic subjects with microalbuminuria.
Diabetologia. Volum: 35, Suppl. 1, Abstract No: 657,
28th Annual Meeting of the European Association for
the Study of Diabetes. September 8-11, 1992, Praque,
Czechoslovakia.
7.Bolu E., Özata
M.,Azal Ö., Çorakcı A., Ayrım A., Beyhan Z.,
Gündogan MA.: Decreased bone mineral density in men
with type-I, insulin-dependent diabetic patients.
Diabetologia. Volum: 35, Suppl. 1, Abstract No: 739,
28th Annual Meeting of the European Association for
the Study of Diabetes. September 8-11, 1992, Praque,
Czechoslovakia.
8.DeGroot LJ.,
Miyamoto T., Suzuki S., Özata M.,Fierro-Renoy F. : T3-TR-TRE
interaction and responses of normal and mutant TRS.
International Workshop on Thyroid Hormone Resistance.
July 10-11, 1993, Cambridge, UK.
9. Özata M. and
DeGroot LJ.: Diagnostic importance of serum
thyroglobulin assay in the follow-up of patients
with differentiated thyroid cancer. Thyroid, Vol.3,
Suppl.1, Abstract No:13. 67th Annual Meeting of
American Thyroid Association. November 10-14, 1993,
Tampa, Florida, USA.
10.Miyamoto T.,
Özata M.,Fierro-Renoy F., Liu RT., DeGroot LJ. :
Role of heterodimerization in dominant negative
suppression of mutant thyroid hormone receptor.
Thyroid, Vol.3, Supplement 1, Abstract No: 237. 67th
Annual Meeting of American Thyroid Association.
November 10-14, 1993, Tampa, Florida, USA.
11.Liu RT., Suzuki
S. Miyamoto T., Takeda T., Özata M., DeGroot LJ.:
Dominant negative effect of TRVa2 does not require
binding to a TRE. 76th Annual Meeting of The
Endocrine Society. June 15-18, 1994, Anaheim,
California, USA.
12.Azal Ö., Özata
M.,Bolu E., ÇorakcıA., Beyhan Z., Erbil K., Gündoğan
MA.: The importance of serum osteocalcin levels in
the early diagnosis of patients with diabetic
osteopenia. 3rd. European Congress of Endocrinology.
July 17-22, 1994, Amsterdam, The Netherlands.
13.Özata M.,Azal
Ö., Çorakçı A., Beyhan Z., Kurt I., Gündogan MA. :
Can we use plasma fibronectin levels as a marker for
early diabetic nephropathy? 3rd. European Congress
of Endocrinology. July 17-22, 1994, Amsterdam, The
Netherlands.
14.Özata M.,Öztürk
E.,Tufan T., Azal Ö., Günalp B.,Pekcan M., Çorakçı
A., Aslan I., Özgüven MA., Beyhan Z., Narin Y., Bolu
E., Dündar S., Bayhan H., Gündo?an MA. : The
clinical course and the value of
99mTc(V)
DMSA, I131
MIBG and thallium-201 imaging techniques in the
follow-up of medullary carcinoma of the thyroid.
First International Congress of Nuclear Oncology.
June 19-23,1994 Istanbul, Turkey.
15. Arslan N., Azal
Ö., Kırılmaz A., Özata M.,Erdöl C., Karaeren H.,
Çorakcı A., Gündogan MA. : Assesment of left
venticular diastolic function with doppler
echocardiography in Type-1 diabetic patients. 30th
Annual Meeting of the European Association for the
Study of Diabetes. Dusseldorf, Germany, 28 September-1
October 1994.
16.Özata M., Bayhan
H., Bingöl N., Dündar S., Ilgın S., Kurt I., Çorakcı
A., and Gündoğan MA. : Sequential changes in serum
TPO following radioiodine therapy of patients with
differentiated thyroid carcinoma. 8th Balkan
Congress of Endocrinology 3-5 May 1995, Bursa,
Turkey.
17.Bolu E., Özata
M., Yakın A., Bedük A., Beyhan Z., Çanakcı Z.,
Çorakcı A., Gündogan MA. : Association of acute
myeloblostic leukemia, schwannoma and colon cancer
in 3 patients with acromegaly. 8th Balkan Congress
of Endocrinology 3-5 May 1995, Bursa, Turkey.
18.Özata M.,Erbil
K., Bolu E., Kenar L., Bulur M., Saglam M., Azal Ö.,
Çorakcı A., Gündogan MA. : Serum total sialic acid
levels in untreated male hypogonadism. 8th Balkan
Congress of Endocrinology 3-5 May 1995, Bursa,
Turkey.
19.Azal Ö.,
Özkardes A., Özata M.,Dolu H., Bolu E., Önde ME.,
Çorakcı A., Gündogan MA. : Visual evoked potentials
in diabetic patients. 8th Balkan Congress of
Endocrinology 3-5 May 1995, Bursa, Turkey.
20.Bolu E., Kurt
I., Özata M.,Beyhan Z., Çorakcı A., Gündogan MA. :
Lipoprotein (a) levels in patients with non-insülin
dependent diabetes mellitus: relationship to
metabolic control . 8th Balkan Congress of
Endocrinology 3-5 May 1995, Bursa, Turkey.
21.Yıldırımkaya M.,
Bilgi C., Özata M., Çorakcı A., Kutluay T.,Gündogan
MA. Karaca L.: Biological variability of serum
lipids and lipoproteins in patients with clinically
well controlled noninsulyn dependent diabetes
mellitus. 8th Balkan Congress of Endocrinology 3-5
May 1995, Bursa, Turkey.
22.Özata M.,Özkardes
A., Azal Ö.,Bolu E., Önde ME., Dolu H., Çorakcı A.,
Gündoğan MA. : Subclinical hypothyroidism does not
lead to alterations either in peripheral nerves or
in brainstem auditory evoked potentials (BAEPs). 8th
Balkan Congress of Endocrinology 3-5 May 1995,
Bursa, Turkey.
23.Bolu E., Yıldız
O., Senöz S., Özata M.,Deniz G.,Azal Ö., Çorakcı A.,
Gündoğan MA. : Effect of dexfenfluramine on food
intake and body weight in rats : analysis of
selection pattern of glucose solutions having
different palatability and coloric values. The 6th
European Congress on Obesity, Copenhagen, Denmark,
May 31-June 3, 1995.
24. Azal Ö.,
Özkardes A., Özata M., Bolu E., Önde ME., Çorakcı
A., Gündoğan MA. : Motor Evoked Potentials in
diabetes mellitus. 31st Annual Meeting of the
European Association for the Study of Diabetes,
Stockholm, Sweden. 12-16 September 1995.
25. Özata M.,
Yıldız A.,Özkardes A., Deniz G., Çorakcı A.,
Gündogan MA. : Effects of aminoguanidine and L-carnitine
on nerve conduction velocities and somatosensorial
evoked potentials in diabetic rats. 31st Annual
Meeting of the European Association for the Study of
Diabetes, Stockholm, Sweden. 12-16 September 1995.
26. Yıldız O.,
Deniz G:,Senöz S., Bolu E., Özata M.,Gündogan MA. :
Anlaysis of the effect of dexfenfluramine on
selection pattern of glucose solutions having
different palatability and caloric values in rats.
First European Congress of Pharmacology . Milan,
Italy, June 16-19, 1995.
27.Yıldız O.,
Köksal V., Senöz S., Bolu E., Özata M., Isımer A.,
Gündogan MA.: High dose dexfenfluramine cause
alveolitis and pulmonary fibrosis in rats. The 7th
European Congress on Obesity, Barcelona, Spain, May
13-15, 1996. Int J Obesity, 20 (suppl 4): 73 Abs
No.08-187-WP1.
28.Yıldırımkaya M.,
Yıldız O., Özata M., Çorakci A., Gündogan MA.:
Effects of L-carnitine on alcohol dehyrogenase in
alloxan-diabetic rats. 32st Annual Meeting of the
European Association for the Study of Diabetes,
Vienna, Austria, 1996.Diabetologia, 39(suppl
1).A236-894,1996.
29.Erbil K., Özata
M., Çakır E., Kenar L.:Serum sialic acid levels in
untreated male hypogonadism. AACC/ CSCC 1996 Annual
Meeting, July 28- August1, 1996. Chicago, USA.
Clinical Chemistry, 42(supply 6) :S229. Abst No:557.
30.Rittig S.,
Siggaard C., Özata M., Yetkin I., Gündo?an MA,
Robertson GL., Pedersen ED.; Substitution of Tyr-2
of the antidiuretic hormone is associated with
familial diabetes insipidus. American Federation for
Clinical Research Midwestern Meeting, September 19-
21, 1996. Chicago, USA. J Invest Med. 44: 387A,
1996.
31.Ozata M.,
Ozkardes A., Çorakci A., Gundosan M.A.: Effects of
acute hypothyroidism on brain-stem auditory evoked
potentials. 9th Balkan Congress of Endocrinology.
Selanik, Yunanistan, 7-11 mayys 1997.
32.Ozata M.,Ozkardes
A.,Beyhan Z., Çorakci A., Gündogan M.A.: Event
related brain potentials in hypothyroidism. 9th
Balkan Congress of Endocrinology. Selanik,
Yunanistan, 7-11 mayıs 1997.
33.Ozata M.,
Yıldırımkaya M., Yılmaz K., Beyhan Z., Çorakci A.,
Gundogan M.A.: The effect of thyroid status on high
density lipoprotein particles. 9th Balkan Congress
of Endocrinology. Selanik, Yunanistan, 7-11 mayıs
1997.
34.Ozata M., Aksu
A., Narin Y., Beyhan Z., Bayhan H., Çorakci A.,
Gundogan M.A.: Is lymphocytic infiltration a
prognostic marker for papillary thyroid carcinoma?
9th Balkan Congress of Endocrinology. Selanik,
Yunanistan, 7-11 mayis 1997.
35.Proenza A.M.,
Poissonnet C.M., Ozata M., Guran S., Gundogan M.A.,
Palou A., Strosberg A.D.:Polymorphism of b3-AR, UCP1
and LPL genes in a Turkish population and its
relationship with obesity. 9th European Congrees of
Obesity, Dublin,Ireland, June 18-21, 1997.
36.Ozata M, Yıldız
O, Senöz S, Kutukcu Y, Aydın A, Corakcı A, Gundogan
MA:Beneficial effects of asetilsalisilik acid on
central and peripheral responses in diabetic rats.
IDF Congress, Helsinki,20-25 July,1997.
37.Ozata M, Yıldız
O, Senoz S, Kutukcu Y, Aydın A, Corakcı A, Gundogan
MA: Effects of aminoguanidine, enalapril, vitamin C,
vitamin E and Vitamin C+E combination on diabetic
neuropathy and nephropaty in streptozotocine-
diabetic rats. IDF congress, Helsinki, Finland, July
20-25,1997.
38..Yönem A., Azal
Ö., Toprak S., Çorakcı A., Ozata M, Gundogan M.A.:
Analysis of patients with Diabetic foot ulcer. IDF
congress, Helsinki, Finland, July 20-25,1997.
39. Ozata M.,
Beyhan Z., Ozışık G., Çağlayan S.,yeşilova Z.,
Bingöl N., Çorakçı A., Özdemir İ.Ç.: Plasma leptin
levels in patients with Klinefelter’s syndrome. IV
European Congress of Endocrinology, Sevilla, Spain,
9-13 May 1998.
40.Ozata M., Beyhan
Z., Salk M., Aydın A., Sayın S., Isımer A., Çorakçı
A., Ozdemir İ.Ç.:Iodine and zinc, but not selenium
and copper deficiency exist in a male Turkish
population with endemic goiter. IV European Congress
of Endocrinology, Sevilla, Spain, 9-13 May 1998.
41.Gul H, Ozata M,
Isimer A, Yildiz O., Ozdemir C. Effects of TRH on
experimental diabetik neuropaty. EASD Congress,
Barceleno, Spain, September, 1998.
42. Özata M,
Özdemir İÇ, Licinio J. Multipl endocrine defects,
decreased sympathetic tone, and immune system
dysfunction in patients with a missense human leptin
gene muatation: new targets for leptin action and
spontaneous correction of leptin- mediated defects.
Proceeding of The Endocrine Society’s 81st
Annual Meeting, June 12-15, 1999, San Diego,
California, U.S.A. P3-67.
43. Enriquez M, Xie
J, Ozata M, Bick DP, Sherins RJ, Bolu E, Ozdemir IÇ,
Layman LC. Pedigree analysis of families with
idiopathic hypogonadatropic hypogonadism. Proceeding
of The Endocrine Society’s 81st
Annual Meeting, June 12-15, 1999, San Diego,
California, U.S.A. P2-157.
44. Layman LC, Gray
MR, Ozata M, Cohen DP, Bolu E, Xie J, Ozdemir IC.The
prevalance of gonadotropin releasing hormone
receptor gene mutations in a population of patients
with idiopathic hypogonadotropic hypogonadism from
Turkey. Proceeding of The Endocrine Society’s 81st
Annual Meeting, June 12-15, 1999, San Diego,
California, U.S.A. P3-371
45. Park J, Ozata
M, Chorich LP, Bick DP, Sherins RJ, Ozdemir IÇ,
Layman LC. Study of the PROP1 gene in a large sample
of patients with idiopathic hypogonadotropic
hypogonadism.The Endocrine Society’s 82nd
Annual Meeting, June 21-24, 2000 Toronto, Canada
46. Ozisik G,
Mergen H, Ozata M, Bolu E, Beyhan Z, Uyanik C,
Caglayan S, Turan M, Oner R, Çorakci A, Kutlu M,
Ozdemir IC, Oner C. Vitamin D receptor gene
polymorphism and vertebral bone density in men with
idiopathic hypogonadotropic hypogonadism. 23 rd
Congress of Endocrinology and Metabolic Diseases of
Turkey Joint meeting with the European Federation of
Endocrine Societies. J Endocrinol Invest. 23:
Supplement to No7, 2000.
47.Ozata M, Uckaya
G, Bolu E, Corapcioglu D, Beyhan Z, Bingol N,
Çorakci A, Kulu M, Özdemir IÇ. Plasma leptin
concentrations in patients with Graves’ disease with
or without ophthalmopathy. 23 rd Congress of
Endocrinology and Metabolic Diseases of Turkey Joint
meeting with the European Federation of Endocrine
Societies. J Endocrinol Invest. 23: Supplement to
No7, 2000.
48.Ozata M,Negrao
AB, Caglayan S, Mantzoros C, Ozdemir IC, Flier JS,
Licinio J.Synchronicity of frequently sampled
circulating leptin and TSH. 23 rd Congress of
Endocrinology and Metabolic Diseases of Turkey Joint
meeting with the European Federation of Endocrine
Societies. J Endocrinol Invest. 23: Supplement to
No7, 2000.
49. Caglayan S,
Ozata M, Ozisik G, Turan M, Bolu E, Beyhan Z,
Corakci A, Kutlu M, Ozdemir İÇ. Hepatic indolamine
metabolism and sympathoadrenal activity in
Klinefelter’s syndrome. 23 rd Congress of
Endocrinology and Metabolic Diseases of Turkey Joint
meeting with the European Federation of Endocrine
Societies. J Endocrinol Invest. 23: Supplement to
No7, 2000.
50. Kilciler G,
Kilciler M, Kutlu M, Ozata M, Oktenli C, Bulucu F.
Hour by hour changes of leptin levels during therapy
after the treatment in patients with idiopathic
hypogonadotropic hypogonadism. 23 rd Congress of
Endocrinology and Metabolic Diseases of Turkey Joint
meeting with the European Federation of Endocrine
Societies. J Endocrinol Invest. 23: Supplement to
No7, 2000
51.Ozata M, Beyhan
Z, Uckaya G, Bolu E, Aydin A, Corakci A, Kutlu M,
Isımer A, Ozdemir IC. Defective antioxidant defense
system in patients with a human leptin gene
mutation. 23 rd Congress of Endocrinology and
Metabolic Diseases of Turkey Joint meeting with the
European Federation of Endocrine Societies. J
Endocrinol Invest. 23: Supplement to No7, 2000
52. Ozata M. Leptin
deficiency and resistance in humans. Symposium. 5th
European Congress of Endocrinology. Turin-Italy,
June 9-13, 2001.
53.Ozata M, Gungor
D, Turan M, Ozisik G, Bingol N, Ozgurtas T, Beyhan
Z, Ozdemir IC. The influence of improved glycemic
control on plasma acylation stimulating protein
(ASP) and leptin in type II diabetic subjects. 5th
European Congress of Endocrinology. Turin-Italy,
June 9-13, 2001.
54.Ozata M, Durmus
O, Yılmaz I, Erdogan M, Bolu E, Ozdemir IC.
Evaluation of aldosterone-renin activity and its
relation with mineral and vitamin D metabolism in
male obesity. . 5th European Congress of
Endocrinology. Turin-Italy, June 9-13, 2001
55.Ozata M, Avcu F,
Durmus O, Sarıbas I, Ozdemir IC, Yalcin A. Leptin
does not play a major role in platelet aggregation
in both obesity and congenital leptin deficiency.
5th European Congress of Endocrinology. Turin-Italy,
June 9-13, 2001
56. Ozata M , Bolu
E, Ozdemir IC, Licinio J. Bone and leptin: of mice
and humans with leptin deficiency. 5th European
Congress of Endocrinology. Turin-Italy, June 9-13,
2001
57. Ozata M ,
Mergen H, Mergen M, Oner C, Ozdemir IC. A novel
melanocortin 4 receptor gene mutation associated
with morbid obesity and psychiatric disorders. 5th
European Congress of Endocrinology. Turin-Italy,
June 9-13, 2001
58. Ozata M,
Öktenli Ç, Vural A, Özdemir IC.. Increaed plasma ASP
concentration in patients with nephrotic syndrome.
22th National Endocrinology congress. 4-9 October,
2001, İstanbul.
59. Ozisik G, Ito
M, Ozata M, Achermann JC, Ozdemir IC, JamesonLJ.
Autosomal dominant neurohypophyseaal diabetes
insipidus caused by a novel muatation that disrupts
the translation start codon in AVP-NPII. The
Endocrine Society’s 84th Annual Meeting, San
Francisco, June 19-22, 2002 USA.
60. Ozata M,
Dieugez C, Casaneuva FF. The Inhibition of Growth
hormone secretion presented in obesity is not
mediated by the high leptin levels. A study in human
leptin deficiency patients. The Endocrine Society’s
84th Annual Meeting, San Francisco, June 19-22, 2002
USA.
Yurtiçi
Kongre Tebliğleri
(Kronolojik sıra)
1.
Özata M., Çorakçı A., Beyhan Z., Azal
Ö., Gündoğan MA.: Diabetes mellitusta serum siyalik
asit düzeyleri. 1990 Diabet Günleri, 4-6 Haziran
1990, Kemer-Antalya.
2.
Özata M., Çorakçı A., Beyhan Z., Azal
Ö., Gündoğan MA.: Diabetes mellitusta serum siyalik
asit düzeylerinin HbA1C
ve fruktozamin düzeyleri ile karşılaştırılması. 1990
Diabet Günleri, 4-6 Haziran 1990, Kemer-Antalya.
3.
Özata M., Beyhan Z., Çorakçı A.,
Gündoğan MA.: Kliniğimizce takip edilen hirsütizmli
olguların değerlendirilmesi ve dekzametazon tedavi
sonuçları. XIV. Ulusal Endokrinoloji Kongresi. 28-29
Eylül 1990, Hacettepe Üniversitesi Merkez Kampusu,
Ankara.
4.
Özata M., Beyhan Z., Çorakçı A.,
Gündo?an MA.: Hirsütizmin cyproteron asetat ve
etinil östradiol ile tedavisi. XIV. Ulusal
Endokrinoloji Kongresi. 28-29 Eylül 1990, Hacettepe
Üniversitesi Merkez Kampusu, Ankara.
5.
Özata M., Beyhan Z., Çorakçı A.,
Gündoğan MA.: Hirsütizm tedavisinde spironolakton.
XIV. Ulusal Endokrinoloji Kongresi. 28-29 Eylül
1990, Hacettepe Üniversitesi Merkez Kampusu, Ankara.
6.
Bolu E., Çorakçy A., Beyhan Z., Özata
M., Gündoğan MA.: Hipogonadizmli erkek olgularda
testosteron seviyeleri ve lipid metabolizması
arasındaki ilişkiler. XIV. Ulusal Endokrinoloji
Kongresi. 28-29 Eylül 1990, Hacettepe Üniversitesi
Merkez Kampusu, Ankara.
7.
Azal Ö., Özata M., Çorakçı A., Beyhan
Z., Bolu E., Hacıbektaşoğlu A., Gündoğan MA.:
Diabetes mellitusta hepatitis B virus antijen ve
antikorları ile karaciğer fonksiyon testleri. 1nci
Ulusal Diabet Kongresi, 27-29 Mayıs 1991,
Silivri-İstanbul.
8.
Çorakçı A., Beyhan Z., Azal Ö., Özata
M., Bolu E., Gündogan MA.: Tip -2 Diabetes
mellitusta dawn fenomeni. 1nci Ulusal Diabet
Kongresi, 27-29 Mayıs 1991, Silivri-İstanbul
|
